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Abstract
Purpose The ideal approach to complex ventral hernia
repair is frequently debated. Differences in processing
techniques among biologic materials may impact hernia
repair outcomes. This study evaluates the outcomes of
hernia repair with a terminally sterilized human acellular
dermal matrix (TS-HADM) (AlloMax Surgical Graft, by
C. R. Bard/Davol, Inc., Warwick, RI, USA) treated with
low-dose gamma irradiation.
Methods A single-arm multi-center retrospective obser-
vational study of patients undergoing hernia repair with
TS-HADM was performed. Data analyses were exploratory
only; no formal hypothesis testing was pre-specified.
Results Seventy-eight patients (43F, 35M) underwent
incisional hernia repair with a TS-HADM. Mean follow-up
was 20.5 months. Preoperative characteristics include age
of 56.6 ± 11.1 years, BMI 36.7 ± 9.9 kg/m2, and mean
hernia defect size 187 cm2. Sixty-five patients underwent
component separation technique (CST) with a reinforcing
graft. Overall, 21.8 % developed recurrences. Recurrences
occurred in 15 % of patients repaired with CST. Major
wound complications occurred in 31 % of patients overall.
Based upon CDC surgical wound classification, major
wound complications were seen in 26, 40, 56, and 50 % of
Class 1, 2, 3, and 4 wounds, respectively. No grafts
required removal.
Conclusions Hernia recurrences are not uncommon fol-
lowing complex abdominal wall reconstruction. Improved
outcomes are seen when a TS-HADM is utilized as rein-
forcement to primary fascial closure.
Keywords Component separation  Human acellular
dermal matrix  Biologic mesh  Ventral hernia
Introduction
Abdominal operations are among some of the most com-
monly performed surgical procedures with an estimate of
4–5 million laparotomies performed annually in the United
States [1]. Although there is considerable interest in hernia
prophylaxis, the incidence of incisional hernia formation
following laparotomy remains significant with a reported
incidence as high as 20 % [2, 3]. The majority of incisional
hernias may be successfully repaired utilizing synthetic
mesh materials with a reasonable recurrence rate [1, 4, 5].
However, a proportion of those patients undergoing inci-
sional hernia repair will develop recurrences and compli-
cations [4, 5]. Prosthetic mesh-related complications
including mesh infections, extrusions, and enterocutaneous
fistulas, although rare, are a significant burden to the health
care system [6]. The management of these complications
and complex recurrent incisional hernias has become an
increasing challenge for surgeons and patients alike owing
to the increase in both morbidity and recurrences among
this group.
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The use of human acellular dermal matrices (HADMs)
for the repair of complex incisional hernias has been
reported extensively [7–13]. Initial reports demonstrated
early successes; however, subsequent reports revealed
hernia recurrence rates approaching 100 % when these
materials were utilized to bridge hernia defects [7].
HADMs are most commonly utilized during hernia pro-
cedures in which there is contamination, infection, or an
increased risk for postoperative wound complications [14].
HADMs appear to be safe when placed into high-risk and
contaminated wounds [10, 11, 13]. In general, the presence
of contamination or infection has been considered a con-
traindication to the utilization of synthetic mesh materials.
Accordingly, HADMs provide surgeons with an alternative
hernia repair strategy when a synthetic mesh is not
appropriate and alternative strategies such as flaps or tissue
transfers would have otherwise been required. When uti-
lized as reinforcement to a component separation hernia
repair, HADMs have been shown to reduce recurrences
[15], although this remains an area of controversy [16].
Although all HADMs originate as donated human tissue,
processing techniques differ which may impact material
properties, host responses, and ultimately surgical out-
comes [17–19].
In this study, we evaluate the outcomes of patients
undergoing complex ventral hernia repair utilizing a termi-
nally sterilized human acellular dermal matrix, AlloMaxTM
Surgical Graft (TS-HADM). Sterilization of the graft occurs
by means of low-dose gamma irradiation. Prior studies have
demonstrated the efficacy of TS-HADM in the repair of
paraesophageal hernias [20], but outcomes following
abdominal wall hernia repair have not been reported.
Methods
After obtaining Institutional Review Board approval, a
single-arm, multi-center, observational study of patients
who had previously undergone hernia repair with a TS-
HADM was performed. Patients who had undergone ven-
tral hernia repair with a TS-HADM a minimum of
9 months prior to study enrollment were included. Con-
sented patients underwent review of medical records for
risk factors for hernia recurrence, procedural details,
complications, and recurrences. Patients without evidence
of hernia recurrence following record review were pro-
spectively evaluated for hernia recurrence by means of a
physical examination. Patients with documented evidence
of hernia recurrence by imaging or prior physical exami-
nation were not required to complete a further physical
examination.
Patients were enrolled at four medical centers including:
Barnes Jewish St. Peters Hospital, St Peters, MO; St.
Francis Hospital, Tulsa, OK; Winthrop University Hospi-
tal, Mineola, NY; and University of Kentucky, Lexington,
KY. Only those patients, at least 18 years of age, who had
undergone a ventral hernia repair with the TS-HADM were
included in the study group. Medical records were
reviewed for risk factors for hernia recurrence including
cancer, infection, obesity, history of prior hernia, immu-
nosuppression, smoking, malnutrition, diabetes mellitus,
anemia, liver disease, pulmonary disease, and prior
abdominal surgery.
Hernia repairs were stratified by the Centers for Disease
Control and Prevention (CDC) surgical wound classifica-
tion which includes Class 1 (clean), Class 2 (clean-con-
taminated), Class 3 (contaminated) and Class 4 (dirty-
infected). Operative details were obtained including oper-
ative date and time, procedure type (use of component
separation, graft location, buttressed or bridging repair,
recurrent or primary), suture type, defect size, graft size,
number of grafts utilized, degree of fascial closure/bridg-
ing, skin closure, hernia wound classification, antibiotic
use, and serum albumin level. Patients were considered to
have an onlay repair if any graft was placed in a location
ventral to the fascial closure, whereas non-onlay repairs
include retro-rectus, preperitoneal, and intraperitoneal
grafts.
Hernia recurrence was defined as any patient in whom
the medical record documented a recurrent bulge by
means of physical examination or radiographic studies or
alternatively patients in whom a recurrent hernia was
detected upon physical examination. Subsets of patient
complications were defined as minor, major skin and soft
tissue complications, seroma or hematoma. Minor com-
plications were defined as cellulitis, epidermolysis,
lymphedema, ecchymosis or erythema. Major skin and
soft tissue complications include superficial wound
infection, abdominal abscess, non-healing wounds, surgi-
cal site infections, postoperative wound infections,
abdominal wall necrosis, and infected hematomas. Sero-
mas and hematomas include only uninfected collections
of fluid or blood, respectively.
Statistical analysis methods
Data from all investigational sites were pooled and sum-
marized. Numerical data such as age, BMI, hernia defect
size were reported as Mean ± SD; while categorical data
such as wound complication rate, recurrence rate were
reported as count and percentages. There was no pre-
planned formal hypothesis for testing. For exploratory
purpose, univariate Chi-square test was used to compare
the rate of wound complications and recurrence rates
among group of subjects classified based on preoperative
Center for Disease Control hernia wound classification.
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Results
Seventy-eight patients were identified who underwent ventral
or incisional hernia repair with a TS-HADM. Repairs were
performed between 2007 and 2010. There were 43 female and
35 male patients with a mean age of 56.6 ± 11.1 years (range
33–85), and a mean body mass index of 36.7 ± 9.9 kg/m2
(range 22–89). Mean follow-up was 622 days (range
274–1,529 days). Forty-seven patients (64 %) underwent
repair for a recurrent hernia. Among recurrent hernia repairs,
the mean number of prior repairs was 2.1 ± 1.5 procedures.
Preoperative patient co-morbidities included smoking, dia-
betes mellitus, anemia, cancer, pulmonary disease, hepatic
disease, immunosuppression, malnutrition, obesity, and
hypoalbuminemia (Table 1). Patients’ preoperative Center
for Disease Control (CDC) wound classification was Class 1
(n = 53, 72 %), Class 2 (n = 10, 14 %), Class 3 (n = 9,
12 %), and Class 4 (n = 2, 3 %).
Seventy-one patients underwent hernia repair with pri-
mary defect closure and placement of a TS-HADM graft as a
reinforcement, of which 65 patients underwent a component
separation procedure. Five patients underwent placement of
a graft as a bridge (Table 2). In two patients, it was unclear
whether the graft was used as a reinforcement or bridge.
Surgical grafts were placed as either an onlay, retromuscular
or preperitoneal underlay, intraperitoneal underlay or uti-
lized a combination of underlay and overlay techniques. The
mean hernia defect size measured intraoperatively was
178 ± 156 cm2, whereas the mean graft size was
348 ± 296 cm2. Hernia recurrences were seen in 17 patients
(21.8 %) and were detected by either physical examination
(n = 9) and/or radiologic imaging (n = 9). Recurrent her-
nias occurred less frequently among those patients who
underwent hernia repair with a reinforcing mesh than other
techniques. Fewer recurrences were also seen in those with
underlay TS-HADM placement (retromuscular, preperito-
neal or intraperitoneal) versus onlay placement, although not
significant (6/33 vs. 11/45, p = 0.508).
Wound complications were seen in patients who under-
went repair with TS-HADM utilizing both onlay and underlay
techniques. The incidence of postoperative seroma was 40 %
in the overlay group, while 21 % of underlay repairs
(including bilayer grafts) developed postoperative seromas
(Table 3). There was a trend toward increased postoperative
major wound complications associated with increasing CDC
surgical wound classification, and no significant impact of
CDC wound class upon recurrences (Table 4).
Discussion
Hernia repair remains as one of the most commonly per-
formed operations in the United States with an increasing
Table 1 Preoperative characteristics
Comorbid conditions n (%)
Current smoker 14 (17.9)
Prior abdominal infection 38 (48.7)
Prior mesh infection 17 (21.8)
Anemia 13 (16.7)
Cancer 17 (21.8)
Diabetes mellitus 26 (33.3)
Immunosuppression 9 (11.5)
Hepatic disease 4 (5.1)
Pulmonary disease 18 (23.1)
Malnutrition 2 (2.6)
Obesity 63 (80.8)
Recurrent hernia 50 (64.1)
Preoperative albumin \3.4 mg/dl 3 (3.8)
Table 2 Operative details and hernia recurrence rates
Graft position n (%) Recurrence
rate n (%)
Onlay 45 (58) 11 (24)
Non-onlay 33 (42) 6 (18)a
Hernia repair technique
Component separation with reinforcing
graft
65 (83) 10 (15)
Defect closure with Reinforcing graft 6 (8) 2 (33)
Bridging graft 5 (7) 4 (80)b
a Onlay/not onlay p = 0.508 (univariate)
b Bridging/reinforcing p = 0.0005 (univariate)
Table 3 Wound complications by graft location
Complications Onlay graft
(n = 45) (%)
Non-onlay graft
(n = 33) (%)
Minor wound complications 11 (24.4) 5 (16)
Major wound complications 16 (35.5) 8 (24)
Seroma 18 (40) 5 (21)
Hematoma 1 (2.2) 3 (9)
Table 4 Major wound complications and hernia recurrences by CDC
wound classification




Class 1/clean 14 (26) 13 (25)
Class 2/clean-contaminated 4 (40) 2 (20)
Class 3/contaminated 5 (56) 0 (0)
Class 4/dirty or infected 1 (50) 0 (0)
* p = 0.068 (univariate)
** p = 0.082 (univariate)
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number of incisional hernia repairs annually [21]. Despite
best practices, hernia recurrences remain a significant
challenge. The use of prosthetic materials has decreased
the incidence of hernia recurrence [1, 4] although there are
clearly unique complications related to the utilization of
synthetic materials for hernia repair [6]. Many techniques
for hernia repair have evolved in an attempt to both min-
imize hernia recurrences and reduce perioperative com-
plications. This study evaluates the results of hernia repairs
performed at four institutions utilizing a TS-HADM.
Although the total number of hernia repairs at these four
institutions was not evaluated, the number of patients
included in this study represents a minority of all ventral
hernias that were performed at these institutions and the
authors believe that synthetic mesh should be utilized for
the overwhelming majority of hernia repairs.
The component separation technique for hernia repair
was described as a unique technique for the management of
complex abdominal wall hernias in situations in which
prosthetic material was felt to be not appropriate or feasible
[22]. Although the initial description of component sepa-
ration did not involve the placement of a reinforcing
prosthetic material, the practice of reinforcing the midline
closure following component separation, in an attempt to
further reduce the risk of recurrence, has been reported [15,
16, 23]. The ideal prosthetic material for reinforcement of
the abdominal wall is an area of tremendous controversy.
Espinosa-de-Los-Monteros described a 13 % reduction in
the risk of hernia recurrences when component separation
hernia repairs were reinforced with a HADM [15]. A more
recent report by Ko et al., however, demonstrated a
reduced rate of hernia recurrence among those patients who
underwent reinforcement with a polypropylene mesh
compared to a HADM [16, 24]. In our series, the recur-
rence rate for patients who underwent component separa-
tion with TS-HADM reinforcement was 15 % with a mean
follow-up of 20.5 months. This recurrence rate is similar to
other reports of reinforced component separation repairs
with either synthetic mesh or biologic grafts [16, 23, 24].
In this study, the majority of patients were considered to
be at increased risk of wound complications and recurrence
due to their pre-existing comorbid conditions. Nearly one-
third of the study population experienced a major wound
complication in this study. Despite this significant inci-
dence of wound complications, there were no patients in
this study who required graft removal. In a study of 545
component separation operations reported by Sailes et al.
[23], there was an increased incidence of mesh infections
seen with synthetic meshes compared with biologic grafts.
Although synthetic mesh infections may be treated non-
operatively, postoperative synthetic mesh infections are a
source of additional morbidity and may necessitate mesh
removal [25]. On the contrary, placement of a biologic
graft at the time of a component separation is unlikely to
result in the need for graft explant even in the presence of a
postoperative infectious complication [8]. The ideal pros-
thetic for reinforcement of contaminated hernias, whether
biologic or synthetic, remains an area of tremendous
debate. It also represents an area in need of further inves-
tigation to clarify both the advantages and drawbacks of
each material in a complex, contaminated or high-risk
hernia repair. In this study population, the risk of hernia
recurrence was similar across patients all CDC wound
classes. This finding is somewhat counterintuitive, but
patient selection was retrospective in this study, and
definitive conclusions about comparative outcomes cannot
be made. Nevertheless, just as major wound complications
were increased with increasing CDC wound class, the
authors would anticipate that recurrence rates would be
increased among patients with higher wound classes.
The utilization of biologic materials in patients with risk
factors for wound complications without active infection or
contamination at the time of surgery remains an area of
great debate. Known risk factors for postoperative skin and
soft tissue infections following surgical procedures include
diabetes, smoking, malnutrition, immunosuppression,
obesity, staphylococcus aureus colonization in the nares,
and remote body site infections [26–28]. Despite best
practices, wound complications in high-risk populations
remain problematic. There is little evidence to suggest that
biologic grafts are superior to synthetic mesh in high-risk
patients undergoing hernia repair [24]. As a result, opera-
tive decisions are often predicated upon local practice
patterns and experience. As this study represents a pro-
spective evaluation of previously operated patients, it is
difficult to fully understand the rationale for the use of a
biologic group for all patients. At the time of the study,
biologic meshes were not uncommonly utilized in patients
with CDC class 1 wounds with known risk factors for
wound infection. Other authors have attempted to create
classification schemes for patients felt to be at increased
risk for wound complications in an attempt to justify the
use of biologic materials [14]. The rationale for utilizing a
biologic material in this group of patients is related to the
potential for postoperative wound complications which
may potentially result in mesh infections. In a study of 995
patients, incisional hernia patients with a prior history of
wound infections were found to have a threefold increase
in wound complications compared to patients without prior
wound infections [29]. While not all wound infections will
result in prosthetic infections, a small percentage of wound
complications can be expected to result in mesh infections
which are more likely to require further surgery.
Although biologic graft repairs are generally more
expensive than synthetic mesh repairs [30], in the event of
a postoperative infection, synthetic meshes are more likely
250 Hernia (2015) 19:247–252
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to require mesh removal [23]. In 2003, the cost of a hos-
pital-acquired infection (pulmonary, bloodstream, urinary,
central nervous system, gastrointestinal, and soft tissue) in
a medical patient was in excess of $15,000 [31]. Although
peer-reviewed data describing the costs of a prosthetic
mesh infection have not been reported in the literature,
presumably the costs associated with mesh explantation
would exceed the cost of treating hospital-acquired infec-
tions in medical patients. Accordingly, decisions for the
utilization of a biologic graft material in patients with risk
factors for wound complications must be individualized
based on local factors and outcomes. In a study of 88
patients with Ventral Hernia Working Group Grade 2
hernias (CDC Grade 1 hernia with risk factors for wound
infection) that underwent repair with synthetic mesh, the
incidence of surgical site infection was 16 % of which only
three patients required mesh excision [32]. Notwithstand-
ing the cost of mesh infections, recurrent hernias add sig-
nificant costs to the healthcare system and significantly
increased recurrence rates are more likely to add to the cost
of healthcare than rare mesh infections.
In the current study, the retrospective design makes it
difficult to discern the rational for the decision to utilize a
TS-HADM over a synthetic mesh. However, the recurrence
rate in our study is substantially lower than the 61 %
recurrence rate reported by Ko et al. [24] in the repair of
non-contaminated hernias with a non-irradiated ADM. The
improved outcomes may be related to patient factors,
technique or alternatively the characteristics of the TS-
HADM. Although the recurrence rate of 30 % in this
patient group is not insignificant, it is not dissimilar to the
recurrence rate reported with other ADMs in complex
hernia repair [33]. In light of the economic health care
climate, both the short-term and long-term costs associated
with hernia care must be carefully considered. Future
prospective trials comparing synthetic and biologic mesh
materials in the high-risk non-contaminated hernia popu-
lation are required to fully understand whether the addi-
tional cost of a biologic mesh compared to synthetic
meshes is warranted.
In this study, the graft utilized to reinforce the hernia
repair is processed with low-dose gamma irradiation to
terminally sterilize the graft. In vitro studies have demon-
strated an increase in the tensile strength of HADMs with
low-dose gamma irradiation and significantly reduced
elasticity without impacting proliferation of fibroblast cells
[34]. Accordingly, the graft processing may impact its
remodeling characteristics and potentially affect hernia
repair outcomes. However, there are no human studies
comparing gamma irradiated and non-gamma irradiated
HADMs in hernia repair.
Abdominal wall reconstruction with a TS-HADM was
associated with a significant hernia recurrence rate in
patients at risk for developing postoperative wound com-
plications. The best outcomes were seen when the TS-
HADM was utilized as a reinforcement to the hernia repair
at the time of a component separation procedure. Although
wound complications occur frequently in this complex
patient population, the need for graft removal is unlikely.
Further prospective studies evaluating TS-HADMs in
hernia repair are needed to define the optimal patient
population for this tissue form.
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